<?xml version="1.0" encoding="UTF-8"?>
<ref id="B85-pharmaceuticals-13-00096">
 <label>85.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gralinski</surname>
    <given-names>L.E.</given-names>
   </name>
   <name>
    <surname>Sheahan</surname>
    <given-names>T.P.</given-names>
   </name>
   <name>
    <surname>Morrison</surname>
    <given-names>T.E.</given-names>
   </name>
   <name>
    <surname>Menachery</surname>
    <given-names>V.D.</given-names>
   </name>
   <name>
    <surname>Jensen</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Leist</surname>
    <given-names>S.R.</given-names>
   </name>
   <name>
    <surname>Whitmore</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Heise</surname>
    <given-names>M.T.</given-names>
   </name>
   <name>
    <surname>Baric</surname>
    <given-names>R.S.</given-names>
   </name>
  </person-group>
  <article-title>Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis</article-title>
  <source>mBio</source>
  <year>2018</year>
  <volume>9</volume>
  <fpage>e01753-18</fpage>
  <pub-id pub-id-type="doi">10.1128/mBio.01753-18</pub-id>
  <?supplied-pmid 30301856?>
  <pub-id pub-id-type="pmid">30301856</pub-id>
 </element-citation>
</ref>
